ECNP/ISCTM Joint Autumn Conference

The meeting addresses key strategic, methodological and regulatory issues affecting CNS clinical trial design and drug development.

Agenda at a glance

9 October	ISCTM/ECNP Welcome Reception
10 October	Session 1: From population to precision psychiatry: Promises, pitfalls, and paths forward Chairs: Andreas Reif, Uma Vaidyanathan Session 2: Current gaps regarding the approval of psychedelic compounds: Design of clinical trials and engagement with regulators Chairs: Gitte Knudsen, Walter Dunn Poster Session/Reception
11 October	Session 3: Uncovering hidden lessons in CNS global clinical trials Chairs: Dennis Hernaus, Dragana Bugarski-Kirola Concurrent working groups: - Accelerating development of psychopathology measures- ISCTM/ECNP Joint working group - Addressing challenges in orphan disease trials working group - Defining and standardising vocal biomarker outcomes working group - Sleep methodology in CNS trials working group